Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Juliusson

Showing results (31-40 of 114) with videos related to

Pageof 12
Sort By:
Hematological Oncology|July 1, 1985
B-CLL cell surface markers and mitogen-induced thymidine uptake: a comparison between lymph node cells and peripheral blood lymphocytes in 25 patientsG Juliusson, K H Robèrt, P Biberfeld
Scandinavian Journal of Immunology|May 1, 1983
Chronic lymphocytic leukaemia cells activated in vitro reveal cellular changes that characterize B-prolymphocytic leukaemia and immunocytomaK H Robèrt, G Juliusson, P Biberfeld
Blood|May 1, 1994
Hairy cell leukemia is characterized by clonal chromosome abnormalities clustered to specific regionsU Haglund, G Juliusson, B Stellan, et al.
European Journal of Clinical Pharmacology|January 1, 1994
Protein binding of 2-chloro 2'-deoxyadenosine (cladribine) in healthy subjects and in patients with leukaemiaF Albertioni, L Herngren, G Juliusson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1992
On the bioavailability of oral and subcutaneous 2-chloro-2'-deoxyadenosine in humans: alternative routes of administrationJ Liliemark, F Albertioni, M Hassan, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1996
A limited sampling strategy for estimation of the cladribine plasma area under the concentration versus time curve after intermittent i.v. infusion, s.c. injection, and oral administrationJ Liliemark, F Albertioni, G Juliusson, et al.
Leukemia|February 3, 1998
Increased frequency of chromosome abnormalities in fibroblasts from hairy cell leukemia patientsU Haglund, B Stellan, G Juliusson, et al.
Ugeskrift for Laeger|November 4, 1996
[Chronic lymphatic leukemia. Peroral cladribine as primary treatment]S B Gjedde, G Juliusson, M M Hansen
Journal of Pharmaceutical and Biomedical Analysis|April 1, 1995
Bioavailability and bacterial degradation of rectally administered 2-chloro-2'-deoxyadenosineJ Liliemark, F Albertioni, C Edlund, et al.
Scandinavian Journal of Gastroenterology|June 13, 2002
Long-term endoscopic remission of crohn disease after autologous stem cell transplantation for acute myeloid leukaemiaJ D Söderholm, C Malm, G Juliusson, et al.
Pageof 12

Showing results (31-40 of 114) with videos related to

Sort By:
Pageof 12
Hematological Oncology|July 1, 1985
B-CLL cell surface markers and mitogen-induced thymidine uptake: a comparison between lymph node cells and peripheral blood lymphocytes in 25 patientsG Juliusson, K H Robèrt, P Biberfeld
Scandinavian Journal of Immunology|May 1, 1983
Chronic lymphocytic leukaemia cells activated in vitro reveal cellular changes that characterize B-prolymphocytic leukaemia and immunocytomaK H Robèrt, G Juliusson, P Biberfeld
Blood|May 1, 1994
Hairy cell leukemia is characterized by clonal chromosome abnormalities clustered to specific regionsU Haglund, G Juliusson, B Stellan, et al.
European Journal of Clinical Pharmacology|January 1, 1994
Protein binding of 2-chloro 2'-deoxyadenosine (cladribine) in healthy subjects and in patients with leukaemiaF Albertioni, L Herngren, G Juliusson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1992
On the bioavailability of oral and subcutaneous 2-chloro-2'-deoxyadenosine in humans: alternative routes of administrationJ Liliemark, F Albertioni, M Hassan, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1996
A limited sampling strategy for estimation of the cladribine plasma area under the concentration versus time curve after intermittent i.v. infusion, s.c. injection, and oral administrationJ Liliemark, F Albertioni, G Juliusson, et al.
Leukemia|February 3, 1998
Increased frequency of chromosome abnormalities in fibroblasts from hairy cell leukemia patientsU Haglund, B Stellan, G Juliusson, et al.
Ugeskrift for Laeger|November 4, 1996
[Chronic lymphatic leukemia. Peroral cladribine as primary treatment]S B Gjedde, G Juliusson, M M Hansen
Journal of Pharmaceutical and Biomedical Analysis|April 1, 1995
Bioavailability and bacterial degradation of rectally administered 2-chloro-2'-deoxyadenosineJ Liliemark, F Albertioni, C Edlund, et al.
Scandinavian Journal of Gastroenterology|June 13, 2002
Long-term endoscopic remission of crohn disease after autologous stem cell transplantation for acute myeloid leukaemiaJ D Söderholm, C Malm, G Juliusson, et al.
Pageof 12